Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
4
×
biotech
clinical trials
eli lilly
indiana blog main
indiana top stories
life sciences
national blog main
amgen
chronic migraine
indiana
teva pharmaceutical
alprazolam
archive
boehringer ingelheim
boston blog main
calcitonin gene-related peptide
cgrp inhibitors
colucid pharmaceuticals
drug enforcement administration
drugs
empagliflozin
episodic migraine
europe
europe blog main
europe top stories
lasmiditan
medical
migraine
migraine research foundation
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
recalls
safety
slgt2 inhibitor
the institute for clinical and economic review
triptans
type 1 diabetes
What
eli
lilly
4
×
approval
drug
fda
announced
migraine
new
won
acute
addresses
approved
bid
blood
boehringer
causes
class
company
condition
decades
decision
develop
developed
diabetes
diabetics
emergency
expand
fallen
friday
giant
giving
glucagon
headache
ingelheim
intended
kit
kits
lasmiditan
late
lilly’s
Language
unset
Current search:
lilly
×
fda
×
@slashgear.com
2 years ago
Emergency low blood sugar kits recalled over loss of potency
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines